Report #2842147

Received May 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NY
Recovered: Unknown
Vaccinated: —
Onset: Apr 1, 2025
Days to onset: —
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTPPVHBHPB	DTAP+IPV+HIB+HEPB (VAXELIS)	MSP VACCINE COMPANY	UNK	—	—
HEP	HEP B (RECOMBIVAX HB)	MERCK & CO. INC.	UNK	—	—

Symptoms (1)

Extra dose administered

Symptom narrative

1 month and 30-day old consumer inadvertently received the RECOMBIVAX HB concomitantly with the VAXELIS vaccine; 1 month and 30-day old consumer inadvertently received the RECOMBIVAX HB concomitantly with the VAXELIS vaccine; This non-serious spontaneous safety report, with reference number 02780823 (interaction number: 02780822), was received by partner on 02-APR-2025 and forwarded on 02-APR-2025 from other health professional. Due to the nature of the event, the causality between the event '1 month and 30-day old consumer inadvertently received the RECOMBIVAX HB concomitantly with the VAXELIS vaccine' and Vaxelis was not applicable. Further information is expected. This non-significant follow-up report, with reference number 02780823 (interaction number: 02780822), was received on 30-APR-2025 from other health professional. Due to the nature of the event, the causality between the event '1 month and 30-day old consumer inadvertently received the RECOMBIVAX HB concomitantly with the VAXELIS vaccine' and Vaxelis was not applicable. Further information is not expected.

Current illness

Prophylaxis